The 13th Annual Conference of the Society of Gastrointestinal Endoscopy of India (SGEI), Endocon 2012, in Kolkata India, featured live procedures of minimally invasive therapies, Secca for Bowel Control Disorder and Stretta for GERD. Both procedures were performed by Dr. Mark Noar, Director of Endoscopic Microsurgery Associates and the Bowel Control Disorder Center in Towson, Maryland. The conference was held April 26-29, 2012 and consisted of academic symposia, as well as live procedures performed at Apollo Gleneagles Hospital. The agenda was constructed based on membership feedback, which showed Secca and Stretta to be therapies of high interest to this physician community.
Dr. Noar shared the latest Stretta data, along with his more than 10 years of Stretta clinical experience at a symposium, and performed both Stretta and Secca procedures for a live audience of conference attendees. Dr. Noar said, “There is certainly an increase in both fecal incontinence and GERD in India. There is upward mobility in society, with a growing middle class, and increased disposable income. This leads to obesity, increased consumption of caffeine and alcohol and stress, all causes of uncontrolled reflux. India, is also a multiparous society, and with multiple births per woman, the risk of fecal incontinence increases directly”. “The procedures were enthusiastically received by the Indian GI community, who felt that the demonstrations made the procedures look easy enough to encourage adoption into normal practice and that the long term data was compelling”, said Dr. Noar.
“Dr. Noar’s presentation of both Stretta and Secca to the participants was widely appreciated by all.” said Dr. Mahesh K. Goenka, Secretary of SGEI and Director of the Institute of Gastrosciences at Apollo Gleneagles Hospitals, Kolkata, India. “Since these were the first Stretta and Secca procedures in the country, it generated a lot of interest among the participants”, said Dr. Goenka.
Endocon 2012 was organized by the SGEI, along with the Kolkata Gastroenterologist Society, and the Indian Society of Gastroenterology West Bengal Chapter. The course was also endorsed by The American Society for Gastrointestinal Endoscopy (ASGE), and the European Society of Gastrointestinal Endoscopy (ESGE).
Bree has been an integral part of Restech from the very beginning. She holds a Masters in Public Health from George Washington University, a BFA from The University of Kansas in Visual Communications, and is a National Board Certified Health & Wellness Coach. Her command of marketing, public health/health delivery systems, and human health behavior change gives her a unique perspective in developing effective marketing strategies for the company.
Physicians: Fill out the form below to complete your request to be added to the “Find-A-Doctor” map on restech.com
Thomas previously worked as a polysomnographic technologist in the Virginia Mason system, before moving into sales with Restech in 2007. After spending 9 years working with distributors across Europe, he was moved into an organizational role at the head office in Houston. In this capacity he works closely with sales and marketing to provide clinical support, manages clinical studies, and provides clinical perspectives on business development. In his spare time Thomas plays rugby for Houston Athletic Rugby Club.
Jeff has over 30 years of experience in the medical device industry and previously worked in sales at companies such as Encision Inc., Interventional Therapies, LLC, Boston Scientific, and United States Surgical Corporation. He has been working as the VP of Sales for Mederi Therapeutics since 2009 and now brings his extensive expertise to Restech. Jeff was part of the team that bridged the Mederi asset sale to Restech. His clinical knowledge of the Stretta and Secca technologies is invaluable. Jeff has three decades of physician relations experience that he brings to Restech as part of the leadership team.
Ray joined Restech in May 2018 as the Vice President for Sales. He has been in the medical device, and specifically in the GERD space for more than 18 years. Starting in sales at Sandhill Scientific pH diagnostics, he moved on to Curon Medical when Stretta and Secca were first introduced to the market. He then worked for Given Imaging when Curon closed operations. When Stretta was relaunced he joined Mederi as VP of Sales. Ray was instrumental in keeping Stretta alive and the customer based informed when Mederi ceased operation and assets were purchased by Restech. He is part of the leadership team directing all product sales for Restech. Ray graduated from Old Dominion University in Norfolk with a BS in Marketing and Business Administration.
Mark is a seasoned professional and Certified Public Accountant in Texas who brings a unique blend of creative vision and financial expertise to any leadership team. He worked as a Senior Executive for 15 years on a leadership team which grew a private equity backed cash logistics company performing at negative EBITDA on $100 million revenue into an international industry leader with superior profitability on revenue exceeding $1.5 billion. In addition, he spent 10 years as a Senior Manager at Price Waterhouse delivering results-oriented merger & acquisition, audit and strategic consulting services to middle market clientele including over 40 manufacturing, distribution, service, nonprofit and technology clients. Mark currently serves as a Chief Financial Officer and consulting CFO (seven years) providing in-house and outsourced CFO and transactional services to the middle market.
Larry is the CTO for Restech and holds a B.S. in Computer Science. He is a software architect specializing in remote patient monitoring, medical sensors, and clinical trial software. Larry holds a patent on massively distributed computing and has worked for a number of major software startup companies including Sybase, Oracle, and Teradata. Larry was also the co-founder of a startup to deliver advanced clinical pathways to patients using mobile devices and medical sensors. Larry is truly a pioneer and now a veteran in the deployment.
Jeff has a breadth of experience with over 25 years in engineering and executive positions within major fortune 100 healthcare companies. He also has proven success in startup medical technology companies. Jeff provides leadership in securing and managing Restech’s patent portfolio. He also built Restech’s compliance platform that established regulatory acceptance in 25+ countries worldwide. Jeff’s scientific support and in-depth understanding of the device industry set the foundation for current and future commercial innovations at Restech.
With nearly 30 years of working with physician thought leaders developing novel and emerging technologies, Leo has played a key role in the development and evolution of balloon angioplasty and stent technologies that revolutionized the therapy of cardiac disease. His experience was instrumental in the development of the patented platform technology which drives the Restech sensor. Leo provides a vision and passion for effecting change in the diagnosis and management of atypical reflux.
With over 20 years of executive experience in both the private and public sector, Debra brings a broad understanding of healthcare delivery system. With experience managing products aimed at wide scale disease and population management for 20 million subscribers, Debra has extensive experience in effectively and efficiently developing models of delivery that address specific health issues. Debra has also been involved in the legislative process and served as the elected President of the Independent Physician Association of California. Debra is dedicated to bringing tools to the healthcare market that improve and support the clinical process.